Open AccessCombined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis
Author(s) -
Seung Hyeok Han,
Ea Wha Kang,
Sumi Yoon,
Hyunse Yoon,
Hyun Chul Lee,
TaeHyun Yoo,
Kyu Hun Choi,
Dong-In Han,
ShinWook Kang
Publication year - 2011
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfr108
Subject(s) - medicine , atorvastatin , valsartan , pulse wave velocity , brachial artery , cardiology , rosuvastatin , peritoneal dialysis , arterial stiffness , urology , kidney disease , statin , renal function , dialysis , blood pressure
Statins and angiotensin receptor blockers (ARBs) are known to improve vascular dysfunction in patients with chronic kidney disease. However, these effects have been inconsistent in dialysis patients. Moreover, it is currently unknown whether adding statins to ARBs improves vascular dysfunction better than ARB monotherapy in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom